Triglyceride (TG), a water insoluble energy-rich lipid, is secreted by the liver as part of very low density lipoproteins to supply energy to extrahepatic tissues. Overproduction of VLDL is associated with increased risk of cardiovascular heart disease, which has renewed interest in factors that affect hepatic TG production. The triglyceride production rate is determined by measuring temporal increases in plasma TG under conditions in which TG hydrolysis by lipoprotein lipase is inhibited. The non-ionic detergent, Triton WR-1339 (Triton), has commonly been used to inhibit lipoprotein lipase for this purpose. Triton, in addition to inhibition of TG hydrolysis, has properties that have the potential to adversely influence lipoprotein metabolism. Another non-ionic detergent, Poloxamer 407 (P-407), also inhibits lipoprotein lipase. In these studies we demonstrate that P-407 is comparable to Triton in the determination of TG production but without the unwanted side effects of Triton.
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Triglyceride (TG) is an energy-rich compound, primarily stored in liver and adipose, and is mobilized in response to various metabolic signals. In plasma, TG, which is water insoluble, circulates as the neutral lipid core of lipoproteins, mainly chylomicrons, which carry dietary fat and are secreted by the small intestine, and very low density lipoprotein (VLDL), which carry triglyceride from the liver. Overproduction of VLDL has been associated with a number of disease states resulting in an increased risk of cardiovascular heart disease (CHD), which has renewed interest in factors that affect hepatic TG (lipoprotein) production (1).
In the early 1950's it was noted that iv injection of certain non-ionic detergents resulted in milky serum that lasted up to 48 hr (2) . This was later shown to be due to the inhibition of triglyceride hydrolysis by lipoprotein lipase (LPL) (3) . Since then lipolysis inhibition has been used to determine hepatic TG production rates, with Triton WR-1339 (also known as Tyloxapol) being widely used. Using this technique, the triglyceride production rate is calculated from the increase in triglyceride over time following detergent injection. While this principle is the basis for most studies on TG production in animals, there is considerable variation in its implementation. Variables include whether mice are fasted, fed chow or a fat-free diet and what the plasma sampling period is (0 to 300 min) over which TG production rates are determined (Table 1) .
In addition to inhibition of LPL, Triton has a number of other physiologic effects related to lipoprotein metabolism. Triton has been shown to cause dissociation of ApoA-I and ApoC-II from HDL (13) . Triton is rapidly taken up by the liver where it accumulates in the lysosomes, causes autophagic vacuole formation (14, 15) and is excreted in bile possibly explaining a reduction in biliary phospholipid and cholesterol output. (16) . These hepatic and plasma effects of Triton may affect hepatic triglyceride production especially over extended periods of time. Our interest was to follow hepatic TG production over prolonged periods, and we sought a potential alternative to Triton with fewer side effects. P-407 (also known as Poloxamer 407) is a non-ionic detergent that was originally used in controlled drug delivery applications (17) . In the early 1990's Johnston, et al. demonstrated that P-407 administration to mice also resulted in hyperlipidemia, later found to be due to lipase inhibition. They have since used this compound to induce hyperlipidemia in various mouse models (Reviewed in 18). In these studies we compare P-407 with Triton in the determination of TG production rate and other effects on lipoprotein metabolism in wild type mice.
MATERIALS AND METHODS

Animals
C57BL/6, Ldlr -/-, and Apoe -/-mice were obtained from Jackson Laboratories.
All mice were housed under standard conditions with a 12 hr light/dark cycle and free access to chow diet (Rodent Diet 5010, Lab Diet, PMI Nutrition International) and water.
Mice were handled according to the guidelines of the University of Pennsylvania Institutional Animal Care and Use Committee.
Hepatic Triglyceride Production Rate
To measure hepatic TG production rate, mice were injected with Triton (Sigma, 500 mg/kg, iv) or P-407 (gift from BASF Customer Care 800-443-0627, 1000 mg/kg, ip) in saline approximately 6 hr into the light cycle, and plasma TG was measured over a 24 hr period. Triton was administered at 500 mg/kg iv, the dose most often employed (Table 1 ) and P-407 at 1,000 mg/kg ip, previously shown by Johnston to be optimal (27) .
In some cases mice were fasted or switched to a fat-free (corn flake) diet 4 hr prior to detergent injection. Immediately prior to injection, and at 1, 2, 6 and 24 hr post injection, blood samples were drawn in heparin capillary tubes, plasma was prepared and TG concentrations were determined. The TG production rate was calculated from the difference in plasma triglyceride levels over a given interval following detergent injection and expressed as umol/kg/hr.
Lipid Analysis
Cholesterol and TG were measured using commercially available kits (Infinity Triglyceride and Cholesterol kit, Thermo Electron Corp.). Hepatic lipids were measured following solubilization of the homogenized tissue with deoxycholate (19) .
For fast protein liquid chromatography (FPLC) analysis, pooled plasma samples from mice of the same experimental group were subjected to FPLC gel filtration by using 2 sequential Superose 6 columns (Pharmacia LKB Biotechnology). Samples were chromatographed at a flow rate of 0.5 mL/min, and fractions of 500 µL each were collected and assayed for TG.
Triton levels were determined in isopropanol extracts of plasma as described by Schurr et al (20) .
Nuclear magnetic resonance (NMR) analysis of particle size was performed on pooled plasma samples by LipoScience, Inc (Richmond, VA) according to the procedure of Otvos (21) .
Lipoprotein Lipase Assay
LPL was assayed as previously described by our lab using conditioned medium containing LPL as the enzyme source except that the assay time was 15 minutes (22).
Triton and P-407 dissolved in PBS were added at various concentrations to determine inhibitory concentration.
VLDL -ApoB clearance:
VLDL (d<1.006 g/ml) was isolated from pooled human plasma and iodinated with 125 I. Mice were injected with either PBS, Triton or P-407 followed by injection with ~5x10 6 cpm of VLDL tracer. Blood samples were collected between 1 min and approximately 24 hrs following tracer injection. ApoB-specific counts were obtained following isopropanol precipitation followed by counting of radioactivity in the apoB precipitate. Tracer data were expressed relative to the 1 minute time point and fractional catabolic rates (FCRs) calculated using a two pool model (23) using WinSAAM.
HDL-ApoA-I analysis:
HDL was obtained by ultracentrifugation. Apolipoproteins were separated by SDS-PAGE using a 3-20% linear gradient. Protein bands were visualized by staining with Coomassie Blue R250.
Statistical Analysis
Values are presented as mean + SD or SEM. Comparisons between P-407 and Triton treated mice were made using the Student's t test (two-tailed).
RESULTS
The physiochemical properties of the two non-ionic detergents, Triton WR-1339, a polyoxyethylene ether of alkyl phenol, and P-407, a block copolymer comprising polyoxyethylene and polyoxypropylene, are shown in Table 2 . The two compounds are inhibitors of lipoprotein lipase with IC 50 's of 12.5 and 4 uM respectively, and the plasma concentrations of each suggest that LPL is completely inhibited for at least 24 hr after administration. P-407 is relatively more hydrophilic than Triton, having a higher hydrophilic/lipophilic balance number (HLB), 22 versus 12.9.
The accumulation of plasma TG was monitored in both male and female C57BL/6 mice administered P-407 or Triton ( Figure 1A ). The rise in plasma TG was similar for both Triton-and P-407-treated mice over the first hour after which the relative TG increase in Triton-treated mice declined with respect to P-407 and plateaued after six hours ( Figure 1A) . A similar effect was observed in both sexes. In contrast, the rate of were both administered at 1,000 mg/kg ip produced similar results (data not shown).
It is possible that the decline in the rate of triglyceride accumulation in Tritontreated mice relative to P-407-treated mice is due to the concentration of Triton in plasma falling to a level that is insufficient to inhibit LPL in plasma. We tested this in two ways. First the concentration of Triton in plasma at 24 hrs was found to be 650 µM, well above what is required for LPL inhibition and in agreement with that obtained in rats (Table 2 ). In addition, we monitored the plasma clearance of 125 I-labeled VLDL ( Figure 2 ). P-407 and Triton are equally effective at reducing the clearance of iodinated VLDL, both detergents capable of reducing clearance by approximately 90% when compared to saline-treated controls. This inhibitory effect of reducing VLDL clearance persisted for at least 24 hours after injection of each detergent. This is in agreement with the fact that both detergents at 24 hr are well above the concentration required to completely inhibit LPL (Table 2 ). This indicates that the decline in the rate of plasma triglyceride accumulation observed with Triton is due to a reduction in the rate of VLDL production.
In order to better understand the decreased TG accumulation with Triton relative to P-407, the plasma and liver lipids were analyzed after 24 hr. The FPLC profile of plasma TG is shown in Figure 3 . In agreement with the TG accumulation data ( Figure   1A ) there is about twice the amount of TG present at 24 hr in the P-407 versus the Triton-treated mice. In addition the P-407 VLDL particles appear larger as the chromatographic profile is shifted slightly to the left with respect to the Triton profile.
This was confirmed by NMR analysis where the mean size of the VLDL particle in mice treated with P-407 was 79.9 nm versus 63.1 nm for Triton-treated animals. Since LPL is thought to be completely inhibited by both Triton and P-407, this might suggest that the secretion of smaller, less TG-rich VLDL in the Triton-treated mice. Triton is known to accumulate in the liver (14, 15) and might affect VLDL-TG secretion.
The analysis of hepatic lipids 24 hr after injection (Figure 4 ) reveals that the TG content in Triton treated mice is increased 4-fold relative to P-407 treatment (30.2 +/-7.0 mg/g liver versus 7.7 +/-1.9 mg/g liver). This increase is specific for TG as the hepatic cholesterol content is similar between the two treatments ( Figure 4B ). Thus Triton treatment may result in sequestration of some of the hepatic TG such that it is not available for secretion. The hepatic lipid content of untreated animals was similar to that of the P-407 treated mice (Figure 4 ).
Triton has also been shown to cause dissociation of apolipoproteins from HDL (13), and we were interested in whether a similar effect is observed with P-407. P-407, unlike Triton, does not result in the destabilization of the HDL particle, again indicating fewer disruptive side effects on lipoprotein metabolism with the use of P-407 ( Figure 5 ).
Finally, because the above studies were done in wild-type mice, we tested the effect of P-407 on plasma TG accumulation in two mouse models where VLDL production has been suggested to be altered, Ldlr -/-and the Apoe -/-mice. It has previously been shown that Apo E is required for normal VLDL secretion (28) although the specific role in the VLDL secretory pathway has yet to be identified. Using Triton, the triglyceride production rate is decreased by 46% in apo E knockout mice compared with wild-type controls (11) . Using P-407, we found a similar 37% decrease in production rate (160 +/-21 µmol/kg/hr versus 101 +/-16 µmol/hr/kg, Figure 6 ). Twisk et al. demonstrated that, in in vitro studies, TG production was increased in primary hepatocytes from LDL knockout mice compared with controls, possibly due to presecretory sequestration or rapid re-uptake of newly synthesized ApoB particles by the LDL receptor (29) . Using Triton to measure production rates in vivo, we previously reported a normal TG production in Ldlr -/-animals (8) . Similarly, using P-407 we find that the TG production rate of Ldlr -/-mice is unaffected compared with wild-type mice ( Figure 6 ).
DISCUSSION
In these studies we compared the use of two non-ionic detergents, Triton and P-407, to obtain hepatic TG production rates in mice. Data combined from several experiments in both sexes in fasted or non-fasted mice were used to analyze the TG production rate ( Figure 1B) . The TG production rate determined with P-407 is constant over a 6 hr time period. The production rate with Triton is similar to that of P-407 when measured over the first hour but steadily decreases when measured over longer time periods. The TG production rate calculated from 0 to 2 hr using P-407, 200 µmol/hr/kg, is on the high end of what has been reported ( Table 1 ). This suggests that investigators who utilize 3 -4 hr time points after Triton injection for determination of production rates may have underestimated the actual rate. Some investigators have delayed collecting initial time point because of an apparent lag in LPL inhibition their studies (7). We did not determine triglyceride levels at times less than one hour. However, because the production rate over the first hour is not significantly different from that over the second hour ( Figure 1B) , a lag in LPL inhibition does not appear to be a significant problem.
We also found that ip injections were more practical than iv injections, with only about 5% failure rate. The use of P-407 allows more flexibility in the bleed times with similar rates obtained for each timed interval used in the calculation ( Figure 1B ).
The decrease in TG production rates when assessed over longer time intervals after Triton injection does not appear to be due to a lack of inhibition of hydrolysis of plasma TG but more likely due to a decrease in the hepatic production rate. This is consistent with the known Triton accumulation in the lysosomes (14, 15) which may affect trafficking of TG from the lysosomes for secretion in VLDL and cause the accumulation of TG in the liver of Triton treated mice ( Figure 4A ). This increase in hepatic TG is not observed with P-407 ( Figure 4A ). In addition, P-407, unlike Triton, did not cause dissolution of the HDL particle ( Figure 5 ). These later two advantages of P-407 may be due to its higher HLB number. The higher HLB may account for the different preferential route of clearance of the two compounds, renal for P-407 (25) and hepatic for Triton (26) .
In summary, the use of P-407 is a preferable alternative to Triton for the determination of hepatic TG production rates and may offer advantages especially if experiments are carried out over an extended time period. 
